Back to Search Start Over

Exposure to Rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

Authors :
Nijland, Hanneke M.J.
Ruslami, Rovina
Stalenhoef, Janneke E.
Nelwan, Erni J.
Alisjahbana, Bachti
Nelwan, Ron H.H.
van der Ven, Andre J.A.M.
Danusantoso, Halim
Aarnoutse, Rob E.
van Crevel, Reinout
Source :
Clinical Infectious Diseases. Oct 1, 2006, Vol. 43 Issue 7, p848, 7 p.
Publication Year :
2006

Subjects

Subjects :
Rifampin -- Usage
Rifampin -- Health aspects
Rifampin -- Research
Tuberculosis -- Drug therapy
Tuberculosis -- Research
Type 2 diabetes -- Drug therapy
Type 2 diabetes -- Health aspects
Type 2 diabetes -- Research
Health
Health care industry

Details

Language :
English
ISSN :
10584838
Volume :
43
Issue :
7
Database :
Gale General OneFile
Journal :
Clinical Infectious Diseases
Publication Type :
Academic Journal
Accession number :
edsgcl.155585800

Tools

Authors Abstract Subjects Details